Biogen (NASDAQ:BIIB) Price Target Lowered to $224.00 at Scotiabank
Biogen (NASDAQ:BIIB – Get Free Report) had its target price lowered by stock analysts at Scotiabank from $244.00 to $224.00 in a research note issued on Thursday,Benzinga reports. The brokerage currently has a “sector outperform” rating on the biotechnology company’s stock. Scotiabank’s price target would suggest a potential upside of 63.11% from the company’s previous […]
Biogen (NASDAQ:BIIB – Get Free Report) had its target price lowered by stock analysts at Scotiabank from $244.00 to $224.00 in a research note issued on Thursday,Benzinga reports. The brokerage currently has a “sector outperform” rating on the biotechnology company’s stock. Scotiabank’s price target would suggest a potential upside of 63.11% from the company’s previous […]
